Data gathered: June 22
AI Stock Analysis - Aditxt (ADTX)
Analysis generated February 18, 2025. Powered by Chat GPT.
Aditxt, a biotechnology company, focuses on improving the health of the immune system. Their main goal is to develop technologies that allow for immune reprogramming, which can address issues such as organ transplantation, autoimmune diseases, and allergies. This innovative approach positions Aditxt at the forefront of a promising yet highly competitive sector. As they continue to evolve, investors will observe both their research outcomes and market acceptance closely.
Stock Alerts - Aditxt (ADTX)
 |
Aditxt | June 5 Price is down by -7.1% in the last 24h. |
|
Aditxt | June 3 Price is up by 7.4% in the last 24h. |
|
Aditxt | June 2 Price is down by -8.1% in the last 24h. |
|
Aditxt | May 30 Price is down by -7.4% in the last 24h. |
Download our app to get future alerts delivered in real-time.
Alternative Data for Aditxt
| Alternative Data | Value | 3m Change | Trend | Benchmark |
|---|---|---|---|---|
| Sentiment | 75 | Sign up | Sign up | Sign up |
| Webpage traffic | 3,000 | Sign up | Sign up | Sign up |
| Google Trends | 11 | Sign up | Sign up | Sign up |
| 4chan Mentions | N/A | Sign up | Sign up | Sign up |
| Reddit Mentions | N/A | Sign up | Sign up | Sign up |
| Stocktwits Mentions | 19 | Sign up | Sign up | Sign up |
| Stocktwits Subscribers | 15,554 | Sign up | Sign up | Sign up |
| Twitter Mentions | 59 | Sign up | Sign up | Sign up |
| News Mentions | N/A | Sign up | Sign up | Sign up |
| Customer reviews | N/A | Sign up | Sign up | Sign up |
About Aditxt
None
| Price | $1.33 |
| Target Price | Sign up |
| Volume | 79,810 |
| Market Cap | $2.8M |
| Year Range | $1.33 - $280 |
| Dividend Yield | 0% |
| PE Ratio | 0 |
| Analyst Rating | 0% buy |
| Industry | Biotechnology |
In the news
 |
Evofem Biosciences’ CEO Saundra Pelletier Joins Aditxt Board of DirectorsJune 8 - Yahoo |
|
Saundra Pelletier, Evofem Biosciences’ CEO, Dr. Friedrich Kapp, Co-CEO of Adimune, and Chris Mitton, President of Pearsanta, Will Join Aditxt Weekly Update on June 6June 4 - Yahoo |
Appili Therapeutics Announces Formal Termination of Arrangement Agreement with Aditxt Inc.May 30 - Financial Post |
|
|
Upcoming Aditxt Weekly Update to Feature Dr. Shahrokh Shabahang, Chief Innovation Officer (CIO) of Aditxt™, and Dr. Friedrich Kapp, Co-CEO of Adimune™, to Discuss Progress of Lead Therapeutic Candidate ADI-100™May 1 - Yahoo |
 |
Why Aditxt Inc. (ADTX) Went Down On Thursday?April 10 - Yahoo Entertainment |
 |
Appili Therapeutics CEO to join Aditxt CEO for weekly update on April 4April 2 - Thefly.com |
Financial performance View All
| Revenue | Cost of Revenue | Gross Profit | Net Income | ebitda | EPS | |
|---|---|---|---|---|---|---|
| Q1 '25 | 1,000 | 0 | 0 | -5.7M | -5.6M | 0.000 |
| Q4 '24 | 3,200 | -73,000 | 76,000 | -5.2M | -27.8B | -40.304 |
| Q3 '24 | 6,900 | 470,000 | -460,000 | -6.9M | -4.6M | -111.069 |
| Q2 '24 | 44,000 | 23,000 | 21,000 | -7.5M | -5.8M | -4.189 |
| Q1 '24 | 80,000 | 210,000 | -130,000 | -15M | -12M | -36.820 |
Insider Transactions View All
| HRT FINANCIAL LP filed to buy 25,434 shares at $1.5. October 17 '24 |
| BNP PARIBAS SECURITIES CORP filed to sell 22,342 shares at $33.2. September 7 '23 |
| Albanna Amro A. filed to buy 1 shares at $20000. July 21 '22 |
Similar companies
Read more about Aditxt (ADTX) and their ai stock analysis, price prediction, earnings, congress trading, insider transactions, technical analysis, sentiment, webpage traffic, google trends, 4chan mentions, reddit mentions, stocktwits mentions, stocktwits subscribers, twitter mentions, news mentions & customer reviews.
What is the Market Cap of Aditxt ?
The Market Cap of Aditxt is $2.8M.
What is Aditxt 's PE Ratio?
As of today, Aditxt 's PE (Price to Earnings) ratio is 0.
What is the current stock price of Aditxt ?
Currently, the price of one share of Aditxt stock is $1.33.
How can I analyze the ADTX stock price chart for investment decisions?
The ADTX stock price chart above provides a comprehensive visual representation of Aditxt 's stock performance over time. Investors can use this chart to identify patterns, trends, and potential support or resistance levels. By examining historical data and recent price movements, investors can make more informed decisions regarding buying, holding, or selling Aditxt shares. Our platform offers an up-to-date ADTX stock price chart, along with technical data analysis and alternative data insights.
Does ADTX offer dividends to its shareholders?
As of our latest update, Aditxt (ADTX) does not offer dividends to its shareholders. Investors interested in Aditxt should consider the potential for capital appreciation as the primary return on investment, rather than expecting dividend payouts.
What are some of the similar stocks of Aditxt ?
Some of the similar stocks of Aditxt are Amgen, Gilead Sciences, Catalyst Pharmaceuticals, Inovio Pharmaceuticals, and Anavex Life Sciences.
.